Study of DE-114 Ophthalmic Solution in Patients With Allergic Conjunctivitis

NCT01363700 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

87

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Conjunctivitis

Interventions

DRUG: DE-114 ophthalmic solution
DRUG: Placebo ophthalmic solution
DRUG: Olopatadine Hydrochloride 0.1% Ophthalmic Solution

Sponsor

Santen Pharmaceutical Co., Ltd.